Valuation Otsuka Holdings Co., Ltd.

Equities

4578

JP3188220002

Pharmaceuticals

Market Closed - Japan Exchange Other stock markets 06:30:00 11/03/2026 GMT			5-day change	1st Jan Change
10,880.00 ^JPY	+6.77%		+7.88%	+22.62%

03-04	Irlab Working to Secure Funding for Phase 3 Study of Mesdopetam - fc	FW
02-26	Irlab Receives $3 Million Milestone Payment Following Dosing in Phase 1b Study	FW

Company Valuation: Otsuka Holdings Co., Ltd.

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	2,261,269	2,336,038	2,870,266	4,618,997	4,686,110	5,378,470	-	-
Change	-	3.31%	22.87%	60.93%	1.45%	14.77%	-	-
Enterprise Value (EV) ¹	1,986,216	2,058,563	2,495,550	4,382,207	4,357,534	4,906,389	4,771,314	4,596,220
Change	-	3.64%	21.23%	75.6%	-0.56%	12.6%	-2.75%	-3.67%
P/E ratio	18x	17.4x	23.6x	13.6x	13x	18.6x	17.1x	14.6x
PBR	1.12x	1.05x	1.2x	1.69x	1.54x	1.66x	1.56x	1.45x
PEG	-	2.57x	-2.54x	0x	1.61x	-0.9x	1.89x	0.9x
Capitalization / Revenue	1.51x	1.34x	1.42x	1.98x	1.9x	2.14x	2.07x	1.98x
EV / Revenue	1.33x	1.18x	1.24x	1.88x	1.76x	1.95x	1.84x	1.69x
EV / EBITDA	8.3x	8.43x	10.5x	10.2x	7.32x	9.56x	8.84x	7.6x
EV / EBIT	12.9x	13.7x	17.9x	13.5x	9.09x	12.7x	11.4x	9.54x
EV / FCF	16.9x	15.8x	34.5x	49.3x	39.2x	17.2x	19.2x	15.9x
FCF Yield	5.91%	6.33%	2.89%	2.03%	2.55%	5.81%	5.22%	6.31%
Dividend per Share ²	100	100	110	120	140	142.7	153.5	162.8
Rate of return	2.4%	2.32%	2.08%	1.4%	1.58%	1.4%	1.51%	1.6%
EPS ²	231.3	247	224.1	633.8	685.1	547.2	596.8	695.8
Distribution rate	43.2%	40.5%	49.1%	18.9%	20.4%	26.1%	25.7%	23.4%
Net sales ¹	1,498,276	1,737,998	2,018,568	2,329,861	2,468,892	2,514,531	2,592,313	2,715,990
EBITDA ¹	239,352	244,084	237,389	431,543	595,542	513,301	539,874	604,958
EBIT ¹	154,497	150,323	139,612	323,564	479,375	385,422	416,889	481,675
Net income ¹	125,463	134,019	121,616	343,120	363,150	288,525	310,449	363,165
Net Debt ¹	-275,053	-277,475	-374,716	-236,790	-328,576	-472,081	-607,156	-782,250
Reference price ²	4,169.00	4,305.00	5,289.00	8,600.00	8,873.00	10,190.00	10,190.00	10,190.00
Nbr of stocks (in thousands)	542,401	542,634	542,686	537,093	528,131	527,818	-	-
Announcement Date	10/02/22	14/02/23	14/02/24	14/02/25	13/02/26	-	-	-

¹JPY in Million²JPY

Estimates

P/E ratio, Detailed evolution

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
OTSUKA HOLDINGS CO., LTD.	18.62x	1.95x	9.56x	1.4%	34.11B
SUN PHARMACEUTICAL INDUSTRIES LTD.	37.27x	7.1x	24.31x	0.82%	47.36B
CIPLA LIMITED	25.71x	3.47x	16.4x	1.03%	11.73B
ZYDUS LIFESCIENCES LIMITED	20.44x	3.54x	13.2x	0.88%	10.11B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	89.72x	-	-	1%	8.76B
KRKA, D. D.	18.7x	3.2x	11.87x	3.59%	8.16B
ONO PHARMACEUTICAL CO., LTD.	16.33x	2.11x	7.97x	3.24%	7.18B
GLENMARK PHARMACEUTICALS LIMITED	35.11x	3.82x	17.36x	0.13%	6.84B
GEDEON RICHTER	9.41x	2.05x	5.55x	4.52%	6.46B
Average	30.14x	3.40x	13.27x	1.85%	15.63B
Weighted average by Cap.	30.31x	4.24x	16.00x	1.41%